Calidi Biotherapeutics (CLDI) Notes Payables (2022 - 2024)
Calidi Biotherapeutics (CLDI) posted quarterly Notes Payables of $1.0 million for Q1 2024, up 660.41% year-over-year from $134269.0 in Q2 2023, and down 31.48% quarter-over-quarter from $1.5 million in Q2 2023.
Calidi Biotherapeutics (CLDI) Notes Payables (2022 - 2024) Analysis & Trends
Calidi Biotherapeutics' Notes Payables history runs 3 years deep, the most recent figure standing at $1.0 million for Q1 2024.
- In Q1 2024, Notes Payables rose 660.41% year-over-year to $1.0 million; the TTM figure through Mar 2024 stood at $1.0 million (up 660.41% YoY), while the FY2022 annual figure was $1.2 million, changed N/A from the prior year.
- Notes Payables for Q1 2024 stood at $1.0 million, down from $1.5 million in the prior quarter.
- The five-year high for Notes Payables was $1.5 million in Q2 2023, with the low at $134269.0 in Q1 2023.
- The 3-year median for Notes Payables is $1.0 million (2024), against an average of $865980.8.
- Peak annual rise in Notes Payables reached 660.41% in 2024, while the deepest fall reached 660.41% in 2024.
- Calidi Biotherapeutics' Notes Payables stood at $1.2 million in 2022, then increased by 21.67% to $1.5 million in 2023, then slumped by 31.48% to $1.0 million in 2024.
- Business Quant data shows CLDI's Notes Payables at $1.0 million in Q1 2024, $1.5 million in Q2 2023, and $134269.0 in Q1 2023.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 140.14 Bn | 132.29 Bn | 2.84 Bn |
| 2 | Regeneron Pharmaceuticals | 87.02 Bn | 79.03 Bn | 3.93 Bn |
| 3 | Argenx Se | 65.30 Bn | 60.12 Bn | 1.37 Bn |
| 4 | Moderna | 60.84 Bn | 55.70 Bn | 52.00 Mn |
| 5 | BeOne Medicines | 42.15 Bn | 37.06 Bn | 1.53 Bn |
| 6 | Alnylam Pharmaceuticals | 31.49 Bn | 28.18 Bn | 992.69 Mn |
| 7 | BioNTech SE | 28.78 Bn | 10.38 Bn | 668.28 Mn |
| 8 | Insmed | 27.55 Bn | 26.39 Bn | 358.27 Mn |
| 9 | Royalty Pharma | 27.14 Bn | 26.31 Bn | - |
| 10 | Calidi Biotherapeutics | 1.98 Mn | -2.12 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2024 | 1.02 Mn |
| Jun 30, 2023 | 1.49 Mn |
| Mar 31, 2023 | 134,269.00 |
| Dec 31, 2022 | 1.22 Mn |
| Sep 30, 2022 | 460,000.00 |